Obese patients who underwent bariatric surgery saw significant and sustained improvements in their Type II diabetes out to 3 years following the procedure, according to research from Johnson & Johnson's Ethicon.
Patients in a clinical study who had bariatric surgery saw sustained improvements in symptoms of Type II diabetes out to 3 years after the procedure, some reporting complete diabetes remission, researchers said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hzgCoI
Cap comentari:
Publica un comentari a l'entrada